Floatz logo

TESTOSTERONE UNDECYLATE

Castration-Resistant Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsSmall moleculePhase 2Active
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
81/ 100

Competitive context

229 Active assets in the Castration-Resistant Prostate Cancer cohort.

Asset / SponsorPhaseRating
Darolutamide
Bayer
Phase 4BBB
Enzalutamide
Prostate Cancer Clinical Trials Consortium
Phase 4BBB
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Ding-Wei Ye
Phase 4BBB
Darolutamide
Bayer
Phase 3BB
Bms-907351
Rana McKay, MD
Phase 3BB

View all 50 →

Same molecule, other indications

TESTOSTERONE UNDECYLATE is also rated in:

hypogonadotropic hypogonadismDormant
A
Indicative ·
82 / 100
View asset →
type 2 diabetes mellitusDormant
BBB
Indicative ·
73 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →